SCHEMBL12366459

SCHEMBL12366459

[C-]#[N+]c1c(C(F)(F)F)cc(-c2cccc(C)c2)n(Cc2ccc(Cl)cc2Cl)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
C5AR1 P21730 4/20 0.37
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
RXRA P19793 1/20 0.36
EPHX2 P34913 1/20 0.35
MDM2 Q00987 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
P2RX7 Q99572 1/20 0.34
TSHR P16473 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
MCTS1 Q9ULC4 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366413 0.93 NR1H2 (0.36) KDM4EALDH1A1HPGDNPSR1L3MBTL1
SCHEMBL12366339 0.90 ALDH1A1 (0.42) KDM4EALDH1A1NR1H2NR1H3RXRA
SCHEMBL12366427 0.89 ALDH1A1 (0.51) KDM4EALDH1A1HPGDNPSR1L3MBTL1
SCHEMBL12366342 0.88 TP53 (0.41) KDM4EALDH1A1HPGDNPSR1MDM2
SCHEMBL12366323 0.86 NR1H2 (0.39) NR1H2NR1H3RXRAMDM2P2RX7
SCHEMBL12366407 0.86 NR1H2 (0.40) NR1H2NR1H3RXRAMDM2LMNA
SCHEMBL12366281 0.85 MDM2 (0.40) KDM4EALDH1A1NPSR1C5AR1NR1H2
SCHEMBL12366463 0.84 RXRA (0.36) KDM4EALDH1A1HPGDNR1H2NR1H3
SCHEMBL12366246 0.84 GAA (0.39) KDM4EALDH1A1NPSR1L3MBTL1C5AR1
SCHEMBL12366250 0.84 MAPT (0.40) MDM2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed